§ Funding Round
Neurophth Therapeutics raised $95M Series C venture round, led by Hubei KTLC.
This funding round does not have an about section yet.
| Investor | Firm Type | Partner |
|---|---|---|
CMG-SDIC Capital | — | — |
Hubei KTLCLEAD | — | — |
| Organization | — | |
wuhanLEAD | Organization | — |
Wuhan Hi-Tech Holding GroupLEAD | — | — |
| Organization | — | |
| Organization | — | |
| Organization | — |
This company has completed 3 funding rounds. Current round is highlighted.
Total Raised
$217M
Top Valuation
-
Neurophth Therapeutics raised $95M in a Series C round.
The round was announced on 08/11/23.
The round was led by Hubei KTLC, wuhan, Wuhan Hi-Tech Holding Group, wuhan optical valley financial holding group, yangtze river-cmb international industry fund.
